Global Chronic Pain Treatment Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Chronic Pain Treatment
- 1.1 Definition of Chronic Pain Treatment
- 1.2 Chronic Pain Treatment Segment by Type
- 1.2.1 Global Chronic Pain Treatment Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Drugs
- 1.2.3 Devices
- 1.3 Chronic Pain Treatment Segment by Applications
- 1.3.1 Global Chronic Pain Treatment Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Nursing Homes
- 1.3.5 Research Centers & Universities
- 1.4 Global Chronic Pain Treatment Overall Market
- 1.4.1 Global Chronic Pain Treatment Revenue (2014-2025)
- 1.4.2 Global Chronic Pain Treatment Production (2014-2025)
- 1.4.3 North America Chronic Pain Treatment Status and Prospect (2014-2025)
- 1.4.4 Europe Chronic Pain Treatment Status and Prospect (2014-2025)
- 1.4.5 China Chronic Pain Treatment Status and Prospect (2014-2025)
- 1.4.6 Japan Chronic Pain Treatment Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Chronic Pain Treatment Status and Prospect (2014-2025)
- 1.4.8 India Chronic Pain Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Chronic Pain Treatment
- 2.3 Manufacturing Process Analysis of Chronic Pain Treatment
- 2.4 Industry Chain Structure of Chronic Pain Treatment
3 Development and Manufacturing Plants Analysis of Chronic Pain Treatment
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Chronic Pain Treatment Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Chronic Pain Treatment
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Chronic Pain Treatment Production and Capacity Analysis
- 4.2 Chronic Pain Treatment Revenue Analysis
- 4.3 Chronic Pain Treatment Price Analysis
- 4.4 Market Concentration Degree
5 Chronic Pain Treatment Regional Market Analysis
- 5.1 Chronic Pain Treatment Production by Regions
- 5.1.1 Global Chronic Pain Treatment Production by Regions
- 5.1.2 Global Chronic Pain Treatment Revenue by Regions
- 5.2 Chronic Pain Treatment Consumption by Regions
- 5.3 North America Chronic Pain Treatment Market Analysis
- 5.3.1 North America Chronic Pain Treatment Production
- 5.3.2 North America Chronic Pain Treatment Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Chronic Pain Treatment Import and Export
- 5.4 Europe Chronic Pain Treatment Market Analysis
- 5.4.1 Europe Chronic Pain Treatment Production
- 5.4.2 Europe Chronic Pain Treatment Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Chronic Pain Treatment Import and Export
- 5.5 China Chronic Pain Treatment Market Analysis
- 5.5.1 China Chronic Pain Treatment Production
- 5.5.2 China Chronic Pain Treatment Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Chronic Pain Treatment Import and Export
- 5.6 Japan Chronic Pain Treatment Market Analysis
- 5.6.1 Japan Chronic Pain Treatment Production
- 5.6.2 Japan Chronic Pain Treatment Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Chronic Pain Treatment Import and Export
- 5.7 Southeast Asia Chronic Pain Treatment Market Analysis
- 5.7.1 Southeast Asia Chronic Pain Treatment Production
- 5.7.2 Southeast Asia Chronic Pain Treatment Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Chronic Pain Treatment Import and Export
- 5.8 India Chronic Pain Treatment Market Analysis
- 5.8.1 India Chronic Pain Treatment Production
- 5.8.2 India Chronic Pain Treatment Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Chronic Pain Treatment Import and Export
6 Chronic Pain Treatment Segment Market Analysis (by Type)
- 6.1 Global Chronic Pain Treatment Production by Type
- 6.2 Global Chronic Pain Treatment Revenue by Type
- 6.3 Chronic Pain Treatment Price by Type
7 Chronic Pain Treatment Segment Market Analysis (by Application)
- 7.1 Global Chronic Pain Treatment Consumption by Application
- 7.2 Global Chronic Pain Treatment Consumption Market Share by Application (2014-2019)
8 Chronic Pain Treatment Major Manufacturers Analysis
- 8.1 Eli Lilly and Company
- 8.1.1 Eli Lilly and Company Chronic Pain Treatment Production Sites and Area Served
- 8.1.2 Eli Lilly and Company Product Introduction, Application and Specification
- 8.1.3 Eli Lilly and Company Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 GlaxoSmithKline
- 8.2.1 GlaxoSmithKline Chronic Pain Treatment Production Sites and Area Served
- 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.2.3 GlaxoSmithKline Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Pfizer
- 8.3.1 Pfizer Chronic Pain Treatment Production Sites and Area Served
- 8.3.2 Pfizer Product Introduction, Application and Specification
- 8.3.3 Pfizer Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Medtronic
- 8.4.1 Medtronic Chronic Pain Treatment Production Sites and Area Served
- 8.4.2 Medtronic Product Introduction, Application and Specification
- 8.4.3 Medtronic Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Abbott Laboratories
- 8.5.1 Abbott Laboratories Chronic Pain Treatment Production Sites and Area Served
- 8.5.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.5.3 Abbott Laboratories Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Boston Scientific Corporation
- 8.6.1 Boston Scientific Corporation Chronic Pain Treatment Production Sites and Area Served
- 8.6.2 Boston Scientific Corporation Product Introduction, Application and Specification
- 8.6.3 Boston Scientific Corporation Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Novartis AG
- 8.7.1 Novartis AG Chronic Pain Treatment Production Sites and Area Served
- 8.7.2 Novartis AG Product Introduction, Application and Specification
- 8.7.3 Novartis AG Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Johnson & Johnson
- 8.8.1 Johnson & Johnson Chronic Pain Treatment Production Sites and Area Served
- 8.8.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.8.3 Johnson & Johnson Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 AstraZeneca PLC
- 8.9.1 AstraZeneca PLC Chronic Pain Treatment Production Sites and Area Served
- 8.9.2 AstraZeneca PLC Product Introduction, Application and Specification
- 8.9.3 AstraZeneca PLC Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Bristol-Myers Squibb
- 8.10.1 Bristol-Myers Squibb Chronic Pain Treatment Production Sites and Area Served
- 8.10.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.10.3 Bristol-Myers Squibb Chronic Pain Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Becton, Dickinson and Company
- 8.12 Sanofi
9 Development Trend of Analysis of Chronic Pain Treatment Market
- 9.1 Global Chronic Pain Treatment Market Trend Analysis
- 9.1.1 Global Chronic Pain Treatment Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Chronic Pain Treatment Regional Market Trend
- 9.2.1 North America Chronic Pain Treatment Forecast 2019-2025
- 9.2.2 Europe Chronic Pain Treatment Forecast 2019-2025
- 9.2.3 China Chronic Pain Treatment Forecast 2019-2025
- 9.2.4 Japan Chronic Pain Treatment Forecast 2019-2025
- 9.2.5 Southeast Asia Chronic Pain Treatment Forecast 2019-2025
- 9.2.6 India Chronic Pain Treatment Forecast 2019-2025
- 9.3 Chronic Pain Treatment Market Trend (Product Type)
- 9.4 Chronic Pain Treatment Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Chronic Pain Treatment Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
This report mainly studies Chronic Pain Treatment market. The market growth is primarily driven by the rising prevalence of chronic conditions, surging geriatric population, and increasing government support toward chronic pain management.
During the forecast period, the chronic pain treatment market is expected to witness the fastest growth in the APAC region.
The global Chronic Pain Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Chronic Pain Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chronic Pain Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Chronic Pain Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Chronic Pain Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Drugs
Devices
Segment by Application
Hospitals
Clinics
Nursing Homes
Research Centers & Universities